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Ezrin, radixin, and moesin (ERM) proteins supply functional linkage between integral membrane proteins and cytoskeleton in mammalian cells
to regulate membrane protein dynamisms and cytoskeleton rearrangement. To assess potential role of the ERM proteins in HIV-1 lifecycle, we
examined if suppression of ERM function in human cells expressing HIV-1 infection receptors influences HIV-1 envelope (Env)-mediated HIV-1-
vector transduction and cell–cell fusion. Expression of an ezrin dominant negative mutant or knockdown of ezrin, radixin, or moesin with siRNA
uniformly decreased transduction titers of HIV-1 vectors having X4-tropic Env. In contrast, transduction titers of R5-tropic Env HIV-1 vectors
were decreased only by radixin knockdown: ezrin knockdown had no detectable effects and moesin knockdown rather increased transduction titer.
Each of the ERM suppressions had no detectable effects on cell surface expression of CD4, CCR5, and CXCR4 or VSV-Env-mediated HIV-1
vector transductions. Finally, the individual knockdown of ERM mRNAs uniformly decreased efficiency of cell–cell fusion mediated by X4- or
R5-tropic Env and HIV-1 infection receptors. These results suggest that (i) the ERM proteins function as positive regulators of infection by X4-
tropic HIV-1, (ii) moesin additionally functions as a negative regulator of R5-tropic HIV-1 virus infection at the early step(s) after the membrane
fusion, and (iii) receptor protein dynamisms are regulated differently in R5- and X4-tropic HIV-1 infections.
© 2008 Elsevier Inc. All rights reserved.Keywords: HIV-1; Ezrin; Radixin; MoesinIntroduction
Human immunodeficiency virus type 1 (HIV-1) enters into
host cells by fusion between viral envelope and host cell
membrane following the binding of HIV-1 envelope glyco-
protein (Env) to the cell surface receptors, CD4 and co-
receptor (CXCR4 or CCR5). The HIV-1 Env glycoprotein is
synthesized as a precursor polyprotein, and cleaved to surface
(SU) and transmembrane (TM) subunits by a cellular protease.
The conformational change of SU subunit by its interaction⁎ Corresponding author. Department of AIDS Research, Institute of Tropical
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doi:10.1016/j.virol.2008.01.047with CD4 triggers the formation and exposure of the co-
receptor binding domain. The binding of SU subunit to the co-
receptor molecule activates the membrane fusion capability of
the viral TM subunit required for the HIV-1 entry into host
cells.
After the HIV-1 Env protein binds to host cells, the HIV-1
infection receptors are clustered (Jolly and Sattentau, 2005;
Nguyen et al., 2005; Viard et al., 2002). The receptor clustering
requires cytoskeletal functions (Iyengar et al., 1998; Jolly et al.,
2004; Kizhatil and Albritton, 1997; Lehmann et al., 2005;
Pontow et al., 2004; Steffens and Hope, 2003). This results in
multiple interactions between the viral Env proteins and the host
receptor molecules on the interacting site between host cell and
virion (Jimenez-Baranda et al., 2007; Platt et al., 1998).
Although accumulating evidence indicates that the cytoskele-
ton-dependent clustering of infection receptors are essential for
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the target cells, there is no evidence that the receptor proteins,
CD4, CXCR4, and CCR5, directly bind to the cytoskeleton.
This suggests that some linker molecules between the receptor
and cytoskeleton is involved in the HIV-1 entry.
Ezrin, radixin, and moesin are the cytosolic proteins called
ERM family that supplies functional linkage between integral
membrane proteins and cytoskeleton (Algrain et al., 1993; Fievet
et al., 2006; Tsukita et al., 1997). They are highly homologous
each other, sharing about 70–80% amino acid identity. The ERM
plays key roles in cell morphogenesis and communication viaFig. 1. Effect of ezrin dominant negative mutant on vector transduction. Panel A. Cell
negative mutant (EZ-N) were subjected to Western immunoblotting using the anti-V
panel. Panel B. Transduction titers of the HIV-1 vector having VSV-G (open bar) or
expressing cells. Relative values to the titer in the control cells are shown. Three ind
Panel C. Cell surface expression of CD4 and CXCR4 in the control and the EZ-N-exp
the first antibody. Open areas indicate cells stained with the anti-CD4 or anti-CXCRregulating membrane protein dynamisms and cytoskeleton
rearrangement (Tsukita et al., 1997). The ERM, particularly
ezrin, is important for reconstructing cell-surface architecture
duringTcell activation (Das et al., 2002; Faure et al., 2004;Gupta
et al., 2006; Roumier et al., 2001). Despite the general similarity
in structure and function, individual function of the three proteins
appears to be specialized (Doi et al., 1999; Kikuchi et al., 2002;
Saotome et al., 2004; Takeuchi et al., 1994). Ezrin is crucial for
formation of local architecture, called immunological synapse, at
the contact site of antigen-presenting and T cells (Gupta et al.,
2006; Roumier et al., 2001). Dephosphorylation and relocation oflysates prepared from cells expressing the VSV-G epitope-tagged ezrin dominant
SV-G epitope antibody. Molecular size markers are indicated in left side of the
NDK HIV-1 Env (closed bar) protein were measured in the control and EZ-N-
ependent experiments were performed. Error bars indicate standard deviations.
ressing cells was analysed by FACS. Closed areas indicate cells stained without
4 antibody.
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brane from the actin cytoskeleton, which presumably increases
lipid raft dynamics and T cell receptor clustering (Gupta et al.,
2006). The immunological synapse contains CD4 and CXCR4
(Roumier et al., 2001), the HIV-1 infection receptors, and its
formation requires cytoskeleton rearrangement (Das et al., 2002).
In addition, theHIV-1 receptors have been reported to co-localize
with ezrin (Steffens and Hope, 2003).
In this study, we examined potential roles of the ERMproteins
in the HIV-1 infection. We prepared HIV-1-susceptible human
cells in which function or expression of the ERM family proteins
were suppressed by either ezrin dominant negative mutant
(Algrain et al., 1993) or by RNA interference technique (Rana,
2007). Suppression of individual ERM in the target cells yielded
distinct effects on HIV-1 vector transductions mediated by the
X4- and R5-tropic Env proteins. The ERM suppressions
uniformly inhibited cell–cell fusion mediated by the X4- and
R5-tropic envelope proteins. Our findings provide for the first
time the evidence that the ERM family proteins function as
pleiotropic regulators of HIV-1 infection.
Results
Ezrin dominant negative mutant inhibits X4-tropic HIV-1 vector
infection
The N-terminal and C-terminal domains of ezrin bind mem-
brane proteins and cytoskeleton, respectively (Tsukita et al.,
1997). Expression of an ezrin N-terminal domain has been
reported to interfere with the endogenous ezrin function as a
dominant negative mutant (Algrain et al., 1993; Roumier et al.,
2001). To examine if the ezrin influences HIV-1 infection, we
prepared human cells expressing the ezrin dominant negative
mutant (EZ-N) that is C-terminally tagged with the VSV-GFig. 2. Effect of ezrin dominant negativemutant onR5-tropic HIV-1 vector transduction
bar) or R5-tropic JRFL (closed bar) Env proteinweremeasured in TE671/CD4/R5 cells
mutant (EZ-N) expression plasmid. Relative titers to that in the EZ-Wt-transfected cells
standard deviations. Panel B. Western immunoblotting of the transfected cells was perf
estimated by their molecular sizes, and are shown by arrows.epitope (Algrain et al., 1993). A murine leukemia virus (MLV)
vector carrying the EZ-N was inoculated into 293T and TE671
cells expressing CD4 (293T/CD4 and TE671/CD4), and the
cells were selected by puromycin. Because the MLV vector
genome contained both of the EZ-N and puromycin-resistant
genes, it was thought that almost all of the puromycin-resistant
cells expressed the EZ-N protein. Western immunoblotting
using the anti-VSV-G epitope antibody indicates that the
puromycin-resistant cell pools expressed the VSV-G-tagged
EZ-N protein as the predicted size (Fig. 1A).
The parental TE671/CD4 and 293T/CD4 cells were suscep-
tible to HIV-1 vector having the X4-tropic NDK HIV-1 Env
protein, because the cells endogenously express CXCR4. Trans-
duction titers of the HIV-1 NDK Env vector in TE671/CD4
and 293T/CD4 cells expressing the EZ-N were constantly
decreased (Fig. 1B). Such reduction in virus titer was observed
when HIV-1 vector having Env protein of a CD4-independent
X4-tropic virus strain, mNDK (Dumonceaux et al., 1998), was
used as a transduction source (data not shown). In contrast, the
EZ-N expression had little effects on the infection of HIV-1
vector having VSV-G protein. Expression of the EZ-N had little
effects on cell surface expression of the HIV-1 receptors, CD4
and CXCR4, as monitored by FACS analysis (Fig. 1C). These
results suggest that ezrin functions as a positive regulator of
HIV-1 infection mediated by the X4-tropic HIV-1 Env but not by
the VSV-Env.
To assess whether the EZ-N affects R5-tropic HIV-1 vector
transduction, transduction titers of the HIV-1 vector having the
R5-tropic JRFLHIV-1 Env protein were measured in target cells
transiently transfected with the VSV-G-tagged wild type ezrin
(EZ-Wt) or the EZ-N expression plasmid. TE671 cells
expressing CD4 and CCR5 (TE671/CD4/R5) were used as the
target cells. The EZ-N reduced transduction titer of the X4-tropic
NDK HIV-1 vector in the TE671/CD4/R5 cells (Fig. 2A). PanelA. Transduction titers of the HIV-1 vector having theX4-tropic NDK (open
transiently transfectedwith thewild type ezrin (EZ-Wt) or ezrin dominant negative
were indicated. This experiment was repeated three times, and error bars indicate
ormed using the anti-VSV-G epitope antibody. The EZ-Wt and EZ-N proteins are
133Y. Kubo et al. / Virology 375 (2008) 130–140compared to the EZ-Wt as control. This result was consistent
with that in the TE671/CD4 cells stably expressing the EZ-N
(Fig. 1B). However, the EZ-N did not significantly affect the R5-
tropic JRFL HIV-1 vector transduction efficiency.Fig. 3. Knockdown of ERM family proteins by siRNAs. Panel A. Effects of siRNA on
siRNA-E1-, siRNA-E2-, siRNA-R-, or siRNA-M-transfected TE671/CD4/R5 cells an
M (3 siRNAs). Semi-quantitative RT-PCR of these total RNA samples was perform
protein expression in human cells. Cell lysates were prepared from 293T, TE671, and
panel), -radixin (middle panel), and -moesin (right panel) antibodies. Molecular size
ezrin protein expression. Cell lysates were prepared from siRNA-GFP (control)- o
mutant. Western immunoblotting of the lysates was performed using the anti-VSV-
siRNA-E1-transfected TE671/CD4/R5 cells. Western immunoblotting of the lysates
siRNA-R on radixin protein expression. TE671/CD4/R5 cells were transiently transfe
cell lysates were prepared from the transfected cells. Western immunoblotting using
CD4/R5 cells transfected with the siRNA-GFP or -R. Western immunoblotting using
M on moesin protein expression. Cell lysates were prepared from TE671/CD4/R5 cell
moesin or anti-actin antibody was performed. Panel F. Effects of these three siRNAs o
simultaneously transfected with siRNA-E2, -R, and -R and from cells transfected
moesin, or anti-actin antibody was performed.Additionally, we analyzed the effects of the EZ-N on trans-
duction activity and syncytium formation of ecotropic MLV Env
proteins in rat XC cells (Kubo et al., 2003). These functions of the
ecotropic MLV Env proteins were not affected by the EZ-NERMmRNA expression. Total RNA samples were isolated from siRNA-GFP-,
d from cells simultaneously transfected with siRNA-E2, siRNA-R, and siRNA-
ed to detect ezrin, radixin, moesin, or GAPDH mRNA. Panel B. ERM family
HeLa cells, and subjected to Western immunoblotting using the anti-ezrin (left
markers are indicated in left side of the panels. Panel C. Effects of siRNA-E1 on
r siRNA-E1-transfected TE671/CD4 cells expressing the VSV-G-tagged EZ-N
G epitope antibody. Cell lysates were prepared from siRNA-GFP- or indicated
was performed using the anti-ezrin or anti-actin antibody. Panel D. Effects of
cted with the HA-tagged radixin expression plasmid and an siRNA indicated, and
the anti-HA antibody was performed. Cell lysates were prepapred from TE671/
the anti-radixin or anti-actin antibody was performed. Panel E. Effects of siRNA-
s transfected with the siRNA-GFP or -M.Western immunoblotting using the anti-
n ERM protein expression. Cell lysates were prepared from TE671/CD4/R5 cells
with siRNA-GFP. Western immunoblotting using anti-ezrin, anti-radixin, anti-
134 Y. Kubo et al. / Virology 375 (2008) 130–140expression (data not shown), indicating that ezrin is not associated
with the ecotropic MLV Env functions.
Knockdown of ERM family protein expression by siRNA inhibits
HIV-1 vector transduction
We were interested in the roles of other ERM family
proteins, i.e., radixin and moesin, in HIV-1 infection. siRNAs
targeting ezrin, radixin, or moesin mRNA was introduced into
the TE671/CD4/R5 cells, and level of the mRNAwas monitored
by semi-quantitative RT-PCR; siRNA-E1 and -E2 target the
ezrin mRNA; siRNA-R targets the radixin mRNA; siRNA-M
targets the moesin mRNA. As shown in Fig. 3A, these siRNAs
specifically and effectively suppressed expression of corre-
sponding ERM family mRNAs in the TE671/CD4/R5 cells.
We next examined if the siRNAs influence expression levels
of the ERM family proteins by Western immunoblotting. As
described in manufacture's documents of the antibodies, the
commercially available antibodies against the ezrin, radixin,Fig. 4. Effect of siRNAs against ERM family genes on HIV-1 vector transduction. HIV
HIV-1 R5-tropic Env (panel C) was inoculated into TE671/CD4/R5 cells transfected
X4R5-tropic NH1 Env protein (panel D) was inoculated into siRNA-transfected TE
transduction titer in the siRNA-GFP-transfected cells were indicated. This experiment
Asterisks indicate statistical significance (Pb0.05). Panel E. Cell surface expressions
analyzed by FACS. Closed areas shows cells stainedwith the FITC-conjugated seconda
the secondary antibody.and moesin had strong cross-reactivity due to the high homol-
ogy within the ERM family proteins. However, we could
distinguish moesin from others by the anti-moesin antibody
because moesin has smaller molecular size (Fig. 3B, anti-
moesin). The moesin was expressed at detectable levels in HeLa
and TE671 cells but not in 293T cells. The data with anti-ezrin
and anti-radixin antibodies suggest that these proteins were
expressed in the three human cells.
To examine siRNA suppression effects on ERM protein
expression, we first used anti-VSV-G antibody and examined if
exogenous expression of the VSV-G-tagged EZ-Nmutant protein
in TE671/CD4/EZ-N cells is suppressed by the siRNA against
ezrin (siRNA-E1). Target sequence of the siRNA-E1 is located in
the N terminal protein-coding region of ezrin mRNA and thus
expression of the EZ-N should be suppressed if the siRNA-E1was
functional. Fig. 3C shows that the siRNA-E1 suppressed the
expression of the VSV-G-tagged EZ-N mutant protein in TE671/
CD4/EZ-N cells, indicating that the siRNA-E1 is functional. As
expected, however, we failed to detect the siRNA suppression-1 vector pseudotyped with VSV-G (panel A), HIV-1 X4-tropic Env (panel B), or
with siRNA-GFP, siRNA-E1, siRNA-R, or siRNA-M. HIV-1 vector having the
671/CD4 (left panel) or TE671/CD4/R5 cells (right panel). Relative values to
was independently repeated three times. Error bars indicate standard deviations.
of CD4, CXCR4, and CCR5 in the siRNA-transfected TE671/CD4/R5 cells were
ry antibody alone, and open areas do cells stainedwith the indicated antibodies and
Fig. 4 (continued ).
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(Fig. 3C), because the anti-ezrin antibody recognizes radixin as
well. Similarly, we failed to confirm suppression of radixin ex-
pression by the siRNA-R with the anti-radixin antibody due to the
cross-reactivity of the antibody (Fig. 3D). Therefore, we con-
structed an expression plasmid of a C-terminally HA-tagged
radixin (Rad-HA) to confirm whether the siRNA-R is functional.
The Rad-HA level in TE671/CD4/R5 cells co-transfected with the
Rad-HA expression plasmid and the siRNA-Rwas lower than that
in cells co-transfected with the Rad-HA expression plasmid and
the siRNA against GFP (Fig. 3D). In contrast, we could confirm
the siRNA-M-mediated suppression of endogenous moesin
protein expression with anti-moesin antibody, because molecular
size of moesin is smaller than ezrin and radixin (Fig. 3E). When
TE671/CD4/R5 cells were simultaneously transfected with the
siRNA-E2, -R, and -M, suppressed expression of ezrin, radixin,
and moesin proteins was detected using the each antibodies(Fig. 3F). Taken together, our results suggest that these siRNAs
inhibit the corresponding protein expression via suppression of
mRNA expression.
Transduction titer of the VSV-G vector was not affected by
these siRNAs (Fig. 4A), suggesting that VSV-envelope-mediated
infection proceeds via ERM-protein independent pathway as
already reported (Kameoka et al., 2007). In contrast, transduction
titers of the X4-tropic NDK and HXB2 vectors were decreased
uniformly by the introduction of siRNA against ezrin, radixin, or
moesin (Fig. 4B). X4-tropic transduction efficiency of the X4R5-
tropic NH1 vector was also inhibited in TE671/CD4 cells
(Fig. 4D), because CC5R is not expressed in the cells. These
results were consistent with the data on the ezrin dominant nega-
tive mutant (Figs. 1 and 2).
The siRNA-R decreased the titers of the R5-tropic vector and
the siRNA-M rather increased the titers (Fig. 4C). These
changes were highly reproducible in the repeated experiments.
136 Y. Kubo et al. / Virology 375 (2008) 130–140These effect of the siRNA-mediated knock down of the ERM
proteins on the HIV-1 infection was not induced by altered cell
surface expression of the HIV-1 receptors, because cell surface
expression of the HIV-1 receptors, CD4, CXCR4, and CCR5,
were not changed by the siRNAs (Fig. 4E). These results
suggest that all of the three ERM family proteins function as
positive regulators of the X4-tropic HIV-1 infection, whereas
radixin and moesin function positive and negative regulators,
respectively, of the R5-tropic HIV-1 infection.
Transduction efficiency of the dual-tropic NH1 vector in
TE671/CD4 cells was suppressed by each of the siRNA (Fig. 4D)
as that of the X4-tropic vector. Because TE671/CD4 cells do not
express CCR5, entry of the dual-tropic NH1 vector occurs only
through CXCR4 in the cells. The moesin knockdown in TE671/
CD4/R5 cells did not enhance transduction efficiency of the dual-
tropic NH1 vector, but did that of the R5-tropic vector. Entry of
theNH1 vectorwas thought to occur through both of CXCR4 and
CCR5 in TE671/CD4/R5 cells. Therefore, the effect of moesin
knockdown on the dual-tropic vector in TE671/CD4/R5 cells
should be different from that on the R5-tropic vector.
To examine if expression of siRNA-resistant ezrin mRNA
abrogate the inhibitory effect of ezrin siRNA on the X4-tropic
HIV-1 vector transduction, we examined effects of siRNA-E2,
which targets 3′ untranslated region (3′UTR) of the ezrin
mRNA, on the X4-tropic virus transduction in the TE671/CD4
cells. The siRNA-E2 reduced the endogenous ezrin mRNA level
(Fig. 3A), but did not suppress exogenous expression of VSV-G-
tagged wild type ezrin (Fig. 5A), because the exogenous mRNA
encoding the VSV-G-tagged ezrin does not contain the 3′UTR.
The siRNA-E2 transfection into TE671/CD4 cells decreased
transduction titer of the NDK HIV-1 vector (Fig. 5B) as the
siRNA-E1 did (Fig. 4B). Expression of the siRNA-resistant
ezrin, i.e., VSV-G-tagged ezrin wild type protein, abrogated theFig. 5. Abrogation of inhibitory effect of ezrin knockdown on HIV-1 vector transdu
TE671/CD4/R5 cells transfected with the siRNA-GFP alone, from cells transfected w
ezrin expression plasmid and the siRNA-E2, and from cells transfected with the ez
performed using the anti-ezrin (upper panel), anti-VSV-G epitope (middle panel), or
with the HIV-1 vector having the NDK Env protein. Relative values to transduction
independently repeated three times. Error bars show standard deviations. Asterisks iinhibitory effect of the siRNA-E2 (Fig. 5B). The VSV-G-tagged
ezrin expression alone did not affect the HIV-1 vector trans-
duction efficiency. These results support the argument that ezrin
is important for increasing efficiency of the X4-tropic HIV-1
infection.
Effects of ERM-family-targeting siRNAs on cell–cell fusion
mediated by HIV-1 Env proteins
To assess whether the ERM family proteins play roles in
HIV-1-Env-mediated membrane fusion, we examined if the
ezrin dominant negative mutant (EZ-N) and siRNAs against the
ERM family proteins influence cell–cell fusion in co-culture of
target cells and NDK Env-expressing 293T cells. In this co-
culture system, we can monitor cell–cell fusion via interac-
tion of HIV-1 Env and HIV-1 infection receptors by using the
β-galactosidase activity (seeMaterials and methods). NDK Env-
mediated cell–cell fusion was inhibited by introduction of either
the EZ-N protein (Fig. 6A), siRNA-E2, -R, or -M (Fig. 6B) into
the receptor expressing cells, consistent with the results obtained
from HIV-1 vector transduction assay (Figs. 1B and 4B). Simi-
larly, JRFL-Env-mediated cell–cell fusion was inhibited by ezrin
and radixin siRNAs (Fig. 6C), although the ezrin siRNA had no
effect on the R5-tropic HIV-1 vector transduction efficiency
(Fig. 4C). The siRNA-M enhanced the vector transduction of the
R5-tropic vector, whereas such enhancement was not observed in
the cell fusion. These effects were highly reproducible in the
repeated experiments.
Discussion
In this study, we examined potential roles of the ERMproteins
in HIV-1 entry. A recent study described the similar topic, inction by exogenous ezrin expression. Panel A. Cell lystaes were prepared from
ith siRNA-E2 alone, from cells co-transfected with the VSV-G-tagged wild type
rin expression plasmid alone. Westerm immunoblotting of the cell lystaes was
anti-actin (lower panel) antibody. Panel B. The transfected cells were inoculated
titer in the siRNA-GFP-transfected cells were indicated. This experiment was
ndicate statistical significance (Pb0.05).
Fig. 6. Effect of ezrin dominant negative mutant and siRNAs against ERM family proteins on HIV-1-Env-mediated cell–cell fusion. 293Tcells were transfected with the
NDK (panels A and B) or JRFL (panel C) Env expression plasmid. TE671/CD4 or TE671/CD4/EZ-N cells transfected with the LTR-LacZ construct were added onto
293T cells transfected with the NDK Env expression plasmid (panel A). TE671/CD4/R5 cells were co-transfected with the each siRNA as indicated and the LTR-LacZ
plasmid. The transfected TE671/CD4/R5 cells were added onto the transfected 293T cells. β-Galactosidase activities of their cell lystaes were measured as described in
Materials and methods. Relative values to β-galactosidase activity of the mixed culture of the siRNA-GFP-transfected TE671/CD4/R5 cells and the Env-transfected
293T cells were indicated. This experiment was repeated three times, and error bars indicate standard deviations. Asterisks indicate statistical significance (Pb0.05).
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microtubule formation and inhibits transduction of HIV-1 vectors
having VSV-G protein in the rat cells (Naghavi et al., 2007). Our
study deals with the similar topic but rather focused on the roles
of the three ERM proteins in HIV-1-Env-mediated infections of
human cells rather than VSV-Env-mediated infection of the
rodent cells. Our study thus could reveal a hitherto unappreciated
regulation mechanism, a pleiotropic regulation of HIV-1 infec-
tion by the ERM proteins.
Each of the siRNA against the ERM family proteins as well
as the dominant negative mutant of ezrin inhibited transduction
of X4-tropic HIV-1 vectors (Figs. 1B and 4B). These inhibitions
were unlikely to be due to the reduced binding events of HIV-1
Env to the infection receptors, because the levels of cell surface
expression of the CD4 and CXCR4 were similar in the ERM-
suppression-positive and -negative cells (Figs. 1C and 4E).
Similarly, the inhibitions were unlikely to be due to the overallreductions in the HIV-1 replication processes, because VSV-G-
mediated HIV-1 transductions were not affected by the ERM
suppression (Figs. 1B and 4A). Alternatively, our results strong-
ly suggest that the ERM suppression induced specific inhibition
of the X4-tropic HIV-1 infection at the entry step(s). Correlation
between the X4-tropic vector transduction inhibition and cell–
cell fusion inhibition (Figs. 4B and 6B) suggests that a key site
of action for the siRNA-mediated inhibition is the membrane
fusion. This in turn implies that the ERM proteins individually
play positive roles in the membrane fusion mediated by
interactions of X4-tropic Env and infection receptors.
Interestingly, transductions of the R5-tropic HIV-1 vectors
were inhibited by the radixin siRNA alone, but were not by the
ezrin and moesin siRNAs (Fig. 4C). The moesin siRNA rather
increased the R5-tropic HIV-1 vector transductions. These results
suggest that radixin of the ERM family is a key molecule for the
efficient R5-tropic HIV-1 infection, whereas moesin rather
138 Y. Kubo et al. / Virology 375 (2008) 130–140suppresses the HIV-1 R5 virus infection. Notably, such bimodal
effects of the ERM proteins were not observed in the R5-tropic-
Env-mediated cell–cell fusion (Fig. 6C). These results suggest
that the ERM proteins including moesin function as positive
regulators of R5-tropic-Env-mediated membrane fusion and that
moesin additionally functions as a negative regulator ofHIV-1R5
virus replication at the early step(s) after the membrane fusion.
Our findings suggest that the ERM proteins regulate dif-
ferently the R5- and X4-tropic HIV-1 infection. Underlying
mechanisms by which the ERM proteins undergo the different
regulation remain to be clarified. In this regard, CCR5 and CD4
co-localize on the plasma membrane before HIV-1 infection
(Steffens and Hope, 2003, 2004), whereas CXCR4 and CD4 do
not (Kozak et al., 2002). Such a difference in cell surface
localization raises a possibility that regulation system for the
CCR5 and CXCR4 fluidity on the plasma membrane is different.
This in turn may lead to distinct regulation of infection receptor
fluidity and cytoskeleton rearrangement by the ERM in CCR5
and CXCR4-mediated HIV-1 infection. However, we cannot
exclude the possibility that the CCR5 over-expression in the
target cells diminishes the ERMprotein function for the R5-tropic
HIV-1 infection (Jimenez-Baranda et al., 2007;Viard et al., 2002).
Recent study has reported that the moesin regulates stable
microtubule formation and inhibits transduction of HIV-1 vectors
having VSV-G protein in the rat cells (Naghavi et al., 2007). The
findings suggest that moesin regulates cytoskeleton rearrange-
ment to suppress HIV-1 replication somewhere after virus entry.
Our data show that knockdown of moesin by siRNA resulted in
enhancement of HIV-1 vector transduction only when the vector
has the R5-tropic Env (Fig. 4C). The results suggest that in the
case of R5-tropic virus infection, the moesin-mediated enhance-
ment of infection is dominant in comparison with moesin-
mediated suppression of HIV-1 replication, if any, after entry. The
EZ-N protein suppressed the X4-tropic HIV-1 infection in
TE671/CD4 and 293T/CD4 cells, but did not significantly in
HeLa/CD4 cells (data not shown). Apparently the inconsistent
results with HIV-1 vectors may imply differences of the moesin-
mediated regulation system in these different cells, although
further study is required for clarifying the issue.
The inhibitory effects of the ezrin dominant negativemutant and
the ERM siRNAs on the HIV-1 vector transduction were not so
high (about 50% reduction). As mentioned above, ERM proteins
are highly homologous each other, and similarly functions,
suggesting a possibility that other members of ERM family pro-
teins complement functions of the proteins suppressed by the
siRNA. Therefore, the target cells were simultaneously transfected
with the siRNAs-E2, -R, and -M. However, the introduction of the
three siRNAs resulted in severe cytotoxicity on the target cells as
reported (Takeuchi et al., 1994), and it was difficult to analyze their
effect on such cells. Transduction titers of the X4-tropic HIV-1
vectors on TE671/CD4 cells transfected with an siRNA against
CXCR4, which actually reduced its expression level, was about
50%of those on theGFP siRNA-transfected cells (data not shown),
like the ERM siRNAs. This result suggests that the ERM proteins
function in X4-tropic HIV-1 entry as importantly as CXCR4 does.
In conclusion, we found that ezrin, radixin, and moesin
proteins functions as pleiotropic regulators of HIV-1 infection inhuman cells. Our findings provide a basis to study HIV-1 entry
in relation to the regulation of membrane protein fluidity and
cytoskeleton rearrangement by the ERM proteins.
Materials and methods
Env protein expression plasmids
AnX4-tropic HIV-1NDKEnv expression plasmidwas kindly
provided by Dr. U. Hazan (Dumonceaux et al., 1998). HIV-1
HXB2 (X4 tropic), JRFL (R5 tropic), NH1 (X4R5-tropic), and
NH2 (R5 tropic) Env expression plasmids were kindly provided
by Dr. Y. Yokomaku (Kusagawa et al., 2002; Yokomaku et al.,
2004). These HIV-1 Env expression plasmids encodes HIV-1 tat
and rev genes as well as the env sequence. AVSV-G expression
plasmid (pHEF-VSV-G) was obtained from Dr. L. Chang
through the AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH, USA (Iwakuma et al., 1999).
Construction of C-terminally HA-tagged radixin expression
plasmid
Total RNA samples were isolated from TE671 cells, and
radixin cDNAwas amplified by PCR using following primers;
Rad-S (5′-GAGAAAGAAAATGCCGAAACC-3′) and Rad-
AS (5′-ATATATGCAAAATAACAGCTCTCA-3′). The radixin
PCR products were ligated into pTarget vector plasmid
(Promega) by TA cloning. The predicted amino acid sequence
of the radixin cDNAwas completely identical to that of already
reported human radixin. The radixin sequence was amplified by
PCR using the Rad-S and Rad-HA (5′-TCATGCGTAATCCG-
GAACATCGTACGGGTATCCCATTGCTTCAAACTCATC-
3′) for C-terminal HA tagging. The antisense Rad-HA primer
contains the HA tag sequence. The PCR product was ligated
into pTarget vector and its nucleotide sequence was confirmed.
HIV-1 vector
A DNA construct (R8.91) that encodes HIV-1 proteins
required for HIV-1 vector preparation except for Env protein
was kindly provided by Dr. D. Trono (Naldini et al., 1996). A
LacZ-containing HIV-1 vector genome expression plasmid
(pTY-EFnLacZ) was obtained from Dr. L. Chang through the
AIDS Research and Reference Reagent Program, Division of
AIDS, NIAID, NIH, USA (Chang et al., 1999).
Cells
Human TE671, 293T, HeLa cell lines were cultured at 37 C
under 5% CO2 in Dulbecco's modified Eagle's medium (Wako)
supplemented with 8% fetal bovine serum (Biosource). CD4-
expressing TE671 and HeLa cells (TE671/CD4 and HeLa/CD4)
were constructed by transfection with a CD4-expression plasmid
containing the neomycin resistant gene. CD4-expressing 293T
cells (293T/CD4) were constructed by transfection with a CD4-
expression plasmid containing the hygromycin resistant gene.
TE671 cells expressing CD4 and CCR5 (TE671/CD4/R5) were
139Y. Kubo et al. / Virology 375 (2008) 130–140constructed as follows. The TE671/CD4 cells were inoculated
with a CCR5 and puromycin-resistant gene-encoding murine
leukemia virus (MLV) vector constructed as reported (Kubo et al.,
2003), and were selected with puromycin. Puromycin-resistant
cell pool was used in this study. TE671 and 293Tcells expressing
CD4 and a C-terminally VSV-G-tagged dominant negative
mutant of ezrin (EZ-N) was constructed by inoculation of the
TE671/CD4 and 293T/CD4 cells with an EZ-N-encoding MLV
vector constructed as reported (Kubo et al., 2003), and designated
as TE671/CD4/EZ-N and 293T/CD4/EZ-N. The VSV-G-tagged
EZ-N plasmid was kindly provided from Dr. M. Arpin.
Transduction assay
To obtain HIV-1 vector particles, 293T cells (5×105) were
plated onto a 10-cm dish and cultured for 2 days. The 293T cells
were transfectedwith the R8.91, pTY-EFnLacZ, and one ofHIV-1
Env expression plasmids. The transfected 293Tcells werewashed
to remove the transfection complex 24 h after transfection, and
continued to be cultured in fresh medium for additional 24 h.
Culture supernatants of the transfected cells were diluted to make
their titer about 60 blue-cell-forming units per a microscopic field
in ezrin dominant negative mutant-free or siRNA-free cells, and
were inoculated into target cells. Target cells (2×105) were plated
onto a 6-cm dish and were inoculated 24 h after the plating. The
inoculated cells were stained with 5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside (X-Gal) (Wako) 2 days after inoculation.
Numbers of blue cells were counted to estimate transduction titers.
Western immunoblotting
Cell lysates were subjected to sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (BioRad), and were transferred
onto a PVDF membrane (Millipore). The membrane was treated
with an anti-VSV-G (Sigma), -ezrin, -radixin, -moesin, or -actin
antibody (Santa Cruz), and then with a horseradish peroxidase-
conjugated protein G (BioRad). Protein G-bound polypeptides
were visualized by ECL Western blotting detection reagents
(Amersham Pharmacia Biotech).
FACS
To analyze cell surface expression of CXCR4 and CCR5,
suspended cells were treated with a rat anti-CXCR4 or -CCR5
antibody (Tanaka et al., 2001). The cells were washed with PBS
3 times, and then treated with an FITC-conjugated anti-rat IgG
antibody (Sigma). The cells were applied to a flow cytometer
(Coulter). To analyze CD4 cell surface expression, cells were
treated with an FITC-conjugated anti-CD4 antibody (Sigma).
Transfection of siRNA
Sequences of sense strands of two siRNAs against ezrin
were GAAUCCUUAGCGAUGAGAUCU (siRNA-E1) and
CCUGAUUCUCGCGAUUAUUCU (siRNA-E2). Sequences
of sense strands of siRNAs against radixin and moesin were
CGACAAGUUAACACCUAAAU (siRNA-R) and CUCCCA-GACGGAUCUGUUGC (siRNA-M). An siRNA against green
fluorescence protein (GFP) was used as control, and sequence
of the sense strand was CUGGAGUUGUCCCAAUUCUUG.
These siRNAs were synthesized by RNAi Co. LTD. Cells were
transfected with one of these siRNAs (200 pmol) by the TransIT
TKO reagent (10 μl) (Mirus). To knockdown expression of all
three ERM family proteins simultaneously, cells were co-trans-
fected with three siRNAs (total 600 pmol) by the transfection
reagent (30 μl).
Semi-quantitative RT-PCR
Total RNA was isolated from siRNA-transfected cells. First
strand cDNA was synthesized from the total RNA with ramdom
hexamer by a reverse transcriptase (TAKARA). Semi-quantitative
PCR was performed using the first strand cDNA as template to
detect ezrin, radixin, moesin, and GAPDH mRNAs. Nucleotide
sequences of the PCR primers for ezrin mRNA were GCA-
CAAACTTACCAG and TGGTCCTGGCCTGGCTGTTA, for
radixin mRNA were GGCAACACAAAGCTTTTGCAG and
ATATATGCAAAATAACAGCTCTCA, for moesin mRNAwere
TGAGGCTGTGGAGTGGCAGCA and CTAGAGGCTGGG-
TGCCCATTA, and for GAPDH mRNAwere AGGTCGGAGT-
CAACGGATTTGGT and GTGGGCCATGAGGTCCACCAC.
These primers were synthesized by Genenet Co. Ltd.
Cell-fusion assay
Receptor protein-expressing cells (2×105) were plasted onto
a 6-cm dish and cultured for 2 days. The cells were co-
transfected with the siRNA and a β-galactosidase expression
plasmid, in which the β-galactosidase gene is under the control
of an HIV-1 long terminal repeat (LTR-LacZ), by the TransIT
TKO transfection reagent (Mirus). 293T cells (2×105) were
plated onto a 6-cm dish and cultured for 2 days. The cells were
transfected with a Tat expression plasmid as control or the HIV-
1 Env expression plasmid by the Lipofectamine transfection
reagent (Invitrogen). The Env expression plmasids additionally
encodes the tat gene. The transfected recipient cells (5×105)
were added onto the HIV-1 Env-expressing 293Tcells 24 h after
transfection. If these cells fuse, the Tat protein activates the β-
galactosidase expression. β-Galactosidase activity of cell
lysates was measured 24 h after mixed culture by the high
sensitive β-galactosidase activity kit (Stratagene).
Statistical analysis
Differences between two groups of data were determined by
the Student's t-test. Statistical significance was set at Pb0.05
for all tests.
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